Caption Management’s Abiomed Inc ABMD Stock Holding History

Caption Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-22,500	Closed	-$5.43M	–	1343
2020 Q2	$5.43M	Buy	+22,500	New	+$4.52M	0.18%	153

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Caption Management's ABMD Position: Q4 2021 in Review

Caption Management sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 2,000 shares — an estimated $651K sold.

Caption Management first reported a position in ABMD in Q3 2019 and held it in 5 quarters. The position peaked at $4.22M in Q4 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

Caption Management reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
Caption Management sold 2,000 Abiomed Inc shares in Q4 2021, an estimated $651K.
Caption Management first reported a position in Abiomed Inc in Q3 2019 and held it in 5 quarters.
Caption Management's Abiomed Inc position peaked at $4.22M in Q4 2020.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.